LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.99 | 84.90 | 3343 | 8212 | 0.4071 | 0.7452 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.99 | 84.90 | 3435 | 8212 | 0.4183 | 0.7524 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 65.70 | 84.90 | 25 | 8484 | 0.0029 | -0.1681 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 65.70 | 84.90 | 3636 | 8484 | 0.4286 | 0.7605 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 65.70 | 84.90 | 118 | 8484 | 0.0139 | 0.0508 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 65.70 | 84.90 | 2700 | 8484 | 0.3182 | 0.6834 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 65.70 | 84.90 | 3517 | 8484 | 0.4145 | 0.7517 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 65.70 | 84.90 | 3582 | 8484 | 0.4222 | 0.7565 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 67.41 | 84.90 | 29 | 8766 | 0.0033 | -0.1483 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 67.41 | 84.90 | 3795 | 8766 | 0.4329 | 0.7647 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 67.41 | 84.90 | 121 | 8766 | 0.0138 | 0.0544 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 67.41 | 84.90 | 2809 | 8766 | 0.3204 | 0.6871 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 67.41 | 84.90 | 3712 | 8766 | 0.4234 | 0.7589 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 67.41 | 84.90 | 3773 | 8766 | 0.4304 | 0.7632 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 69.11 | 84.90 | 43 | 8988 | 0.0048 | -0.0962 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 69.11 | 84.90 | 3951 | 8988 | 0.4396 | 0.7700 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 69.11 | 84.90 | 156 | 8988 | 0.0174 | 0.0947 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 69.11 | 84.90 | 2919 | 8988 | 0.3248 | 0.6921 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 69.11 | 84.90 | 3843 | 8988 | 0.4276 | 0.7627 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 69.11 | 84.90 | 3907 | 8988 | 0.4347 | 0.7670 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.81 | 84.90 | 43 | 9132 | 0.0047 | -0.0959 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.81 | 84.90 | 4099 | 9132 | 0.4489 | 0.7762 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.81 | 84.90 | 147 | 9132 | 0.0161 | 0.0847 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.81 | 84.90 | 3032 | 9132 | 0.3320 | 0.6986 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.81 | 84.90 | 3971 | 9132 | 0.4348 | 0.7678 | MN20160318_Q02 | K06 |